Evidence map›Paper›PMID 30765904›Full record

ReviewAustralian prescriber2019

Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Bradley J Gardiner, Andrew J Stewardson, Iain J Abbott, Anton Y Peleg

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Australian prescriber, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05055544 (BeaRberry in the Treatment of Acute UncoMplIcated Cystitis), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05055544 naunknown statusnot on this mapstarted 2021, after this paper: background citation

BeaRberry in the Treatment of Acute UncoMplIcated Cystitis (BRUMI)- Protocol of a Multicentre, Randomized Double-Blind Clinical Trial

TypeinterventionalSponsorUniversity of PecsRan2021 to 2025Enrolled504ConditionsCystitisArmsFosfomycin, Bearberry
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 142 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Nemonoxacin pharmacokinetics/pharmacodynamics againstAntimicrobial agents and chemotherapy · 2026
    Article
  5. Article
  6. Article
  7. Therapeutic strategies for multi-resistantJAC-antimicrobial resistance · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Review
  14. Unlocking Nitrofurantoin: Understanding Molecular Mechanisms of Action and Resistance in Enterobacterales.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  15. Article
  16. Article
  17. The Prevalence of Multidrug-ResistantIndian journal of microbiology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bradley J GardinerDepartment of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.
Andrew J StewardsonDepartment of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.
Iain J AbbottDepartment of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.
Anton Y PelegDepartment of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.
Erasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UNCOMPLICATED URINARY TRACT INFECTION IS ONE OF THE MOST COMMON INDICATIONS FOR ANTIBIOTIC USE IN THE COMMUNITY HOWEVER THE GRAM-NEGATIVE ORGANISMS THAT CAN CAUSE THE INFECTION ARE BECOMING MORE RESISTANT TO ANTIBIOTICS: MANY MULTIDRUG RESISTANT ORGANISMS RETAIN SUSCEPTIBILITY TO TWO OLD ANTIBIOTICS NITROFURANTOIN AND FOSFOMYCIN ADVANTAGES OVER NEWER DRUGS INCLUDE THEIR HIGH URINARY CONCENTRATIONS AND MINIMAL TOXICITY: FOSFOMYCIN IS A POTENTIAL TREATMENT OPTION FOR PATIENTS WITH UNCOMPLICATED URINARY TRACT INFECTION DUE TO RESISTANT ORGANISMS NITROFURANTOIN MAY BE MORE EFFECTIVE AND CAN BE USED FOR URINARY INFECTIONS IN PREGNANT WOMEN:

Indexed as

antibiotic resistancefosfomycinnitrofurantoinurinary tract infection

Identifiers

PMID30765904
PMCPMC6370609
OpenAlexW2913022205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.